CONTENTS
Assistant Editor
Special Assignments
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: (021) 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail :
Editorial BOARD
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published six
times a year.
Copyright:
Clinics Cardive Publishing, Pty, Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on
Pubmed
Audited circulation
Full text articles available on:
or via
co.za; for access codes contact
User ID: cvja8
Password: cvja8
Subscriptions for six issues:
South Africa: R300 (excl VAT)
Other African countries: $30
Overseas: Institutions: R845 ($82)
Individuals: R1 080 ($105)
The views and opinions expressed
in the articles and reviews published
are those of the authors and do not
necessarily reflect those of the editors
of the Journal or its sponsors. In all
clinical instances, medical practitioners
are referred to the product insert
documentation as approved by the
relevant control authorities.
VOL 22, NO 2. MARCH / APRIL 2011
85 Serum high-sensitivity C-reactive protein, amyloid-associated protein and N-terminal
proBNP levels do not predict reversible myocardial ischaemia
M Başkurt • F Aktürk • K Keskin • P Canbolat • B Karadag • A Kaya • A Yildiz • U Coskun •
K Kilickesmez • O Esen • Sk Muniboglu
Case Reports
90 Isolated left ventricular non-compaction with normal ejection fraction
F Peters • C Dos Santos • R Essop
93 Reversible myocardial stunning due to carbon monoxide exposure
H Fotbolcu • O Incedere • RB Bakal • AC Tanalp • Ma Astarcioglu • I Dindar
96 Secondary intracardiac Burkitt-like lymphoma in the absence of HIV infection
AO Mocumbi • L Paul • L Maciel • P Silva • MB Ferreira
Opinions in Hypertension Management
98 Affordable hypertension therapy for diabetic patients
J Aalbers
101 Simultaneous treatment of blood pressure and cholesterol beats the ‘SILO’ approach in
lowering cardiovascular risk: results of the CRUCIAL study
J Aalbers
Drug Trends
102 Primary prevention with statins is more cost-effective
J Aalbers
Stroke prevention in atrial fibrillation
P Wagenaar
Stroke risk reduction: focus of the new
ESC guidelines
J Aalbers
Prasugrel offers consistent platelet control
in appropriate patients requiring treatment
J Aalbers
Substantial evidence for colorectal cancer
reduction with daily low-dose aspirin
J Aalbers
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
